A new generation of anti-obesity drugs aims for greater effectiveness, fewer side effects, and more convenience.
We recently published a list of the 12 Most Oversold Healthcare Stocks to Buy Now. In this article, we are going to take a ...
More than three dozen attorneys general are urging the FDA to take “decisive action” against counterfeit obesity drugs.
American demand for weight-loss drugs is supercharging Denmark’s economy and transforming a small Danish community into an ...
16h
GlobalData on MSNZealand Pharma steadfastly upholds amylin-based obesity drug strategyZealand’s CEO Adam Steensberg said that the company is “exactly where it wants to be” in terms of its partnering and ...
Eli Lilly Chief Scientific Officer Dan Skovronsky spoke to CNBC about obesity pills and more on the future of weight loss.
Discover Zealand Pharma's Q4 2024 earning highlights, key obesity pipeline advancements, and future plans for petrelintide and dapiglutide.
Eli Lilly is betting big on its experimental oral weight-loss drug even before reporting data from its late-stage trial by ...
Boehringer Ingelheim Pharmaceuticals, Inc. Welcomes Brian Hilberdink As President, U.S. Human Pharma
Industry veteran to join Boehringer to advance pipeline and drive new product launches, addressing significant unmet patient needs RIDGEFIE ...
Walmart’s stock fell Thursday as quarterly earnings were expected to decline for the first time in three years, with strength in groceries and GLP-1 drug sales continuing to pressure margins.
One participant lost 22% of her weight in nine months — substantially faster than the rate seen with approved GLP-1 drugs ...
A Georgia farmer said on Wednesday (February 19) he has had to limit sales of his eggs, as shoppers across the U.S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results